Correction to: Leukemia (2012) 26, 149–157; doi:10.1038/leu.2011.196
Since the publication of this paper, the authors have noticed that one of the author names in the appendix was incorrectly listed as Hareth Nari. It should be listed as follows:
Hareth Nahi, Karolinska University Hospital, Stockholm, Sweden.
The authors apologise for any inconvenience caused.
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1038/leu.2011.196
Rights and permissions
About this article
Cite this article
Kumar, S., Lee, J., Lahuerta, J. et al. Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study. Leukemia 26, 1153 (2012). https://doi.org/10.1038/leu.2012.15
Published:
Issue date:
DOI: https://doi.org/10.1038/leu.2012.15
